Gene: TEK
Official Full Name: TEK receptor tyrosine kinaseprovided by HGNC
Gene Summary: This gene encodes a receptor that belongs to the protein tyrosine kinase Tie2 family. The encoded protein possesses a unique extracellular region that contains two immunoglobulin-like domains, three epidermal growth factor (EGF)-like domains and three fibronectin type III repeats. The ligand angiopoietin-1 binds to this receptor and mediates a signaling pathway that functions in embryonic vascular development. Mutations in this gene are associated with inherited venous malformations of the skin and mucous membranes. Alternative splicing results in multiple transcript variants. Additional alternatively spliced transcript variants of this gene have been described, but their full-length nature is not known. [provided by RefSeq, Feb 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10464 | TEK Knockout cell line (HeLa) | Human | TEK | 1:3~1:6 | Negative | Online Inquiry |
TEK Gene Knockout Cell Lines are genetically engineered cell lines in which the TEK gene, which encodes the angiopoietin receptor Tie2, has been specifically disrupted or "knocked out." This innovative biologically relevant product provides researchers with a robust tool for studying the role of the TEK gene in vascular development, angiogenesis, and related cellular processes. By eliminating the expression of this crucial gene, scientists can investigate the consequences of TEK signaling disruptions, providing vital insights into various pathophysiological conditions, including cancer, cardiovascular diseases, and other disorders reliant on vascularization.
The functionality of TEK Gene Knockout Cell Lines lies in their ability to mimic specific biological pathways devoid of TEK signaling, allowing for in-depth analysis of downstream effects and compensatory mechanisms. The absence of Tie2 alters endothelial cell behavior, which is pivotal in understanding how blood vessels form and stabilize, and how this process can go awry in disease contexts. This model can also facilitate high-throughput screening for therapeutic compounds aimed at modulating angiogenesis.
In a scientific landscape where precise gene manipulation is key, TEK Gene Knockout Cell Lines offer significant value in both research and clinical settings. They provide researchers with the ability to discern the intricate roles of angiogenic factors in health and disease, and serve as a powerful model for drug discovery and development.
Compared to conventional models, the TEK Gene Knockout Cell Lines provide a clear advantage by offering a targeted approach to gene disruption, enabling more reproducible and interpretable results. Their specificity enhances the reliability of experimental data, which is crucial for advancing our understanding of complex biological systems.
For researchers and clinicians focused on vascular biology or disease mechanisms, the TEK Gene Knockout Cell Lines represent an indispensable resource. Our company prides itself on its commitment to providing cutting-edge genetic tools and fostering scientific inquiry, ensuring our customers have access to high-quality products that propel their research forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.